% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Tichanek:282727,
      author       = {F. Tichanek and A. Försti$^*$ and A. Hemminki and O.
                      Hemminki and K. Hemminki$^*$},
      title        = {{L}ong-{T}erm {P}eriodic and {C}onditional {S}urvival
                      {T}rends in {P}rostate, {T}esticular, and {P}enile {C}ancers
                      in the {N}ordic {C}ountries, {M}arking {T}iming of
                      {I}mprovements.},
      journal      = {Cancers},
      volume       = {15},
      number       = {17},
      issn         = {2072-6694},
      address      = {Basel},
      publisher    = {MDPI},
      reportid     = {DKFZ-2023-01853},
      pages        = {4261},
      year         = {2023},
      note         = {#LA:C020#},
      abstract     = {Survival studies are important tools for cancer control,
                      but long-term survival data on high-quality cancer
                      registries are lacking for all cancers, including prostate
                      (PC), testicular (TC), and penile cancers. Using generalized
                      additive models and data from the NORDCAN database, we
                      analyzed 1- and 5-year relative survival for these cancers
                      in Denmark (DK), Finland (FI), Norway (NO), and Sweden (SE)
                      over a 50-year period (1971-2020). We additionally estimated
                      conditional 5/1-year survival for patients who survived the
                      1st year after diagnosis. Survival improved early for TC,
                      and 5-year survival reached $90\%$ between 1985 (SE) and
                      2000 (FI). Towards the end of the follow-up, the TC patients
                      who had survived the 1st year survived the next 4 years with
                      comparable probability to the background population. For PC,
                      the $90\%$ landmark was reached between 2000 (FI) and after
                      2010 (DK). For penile cancer, 5-year survival never reached
                      the $90\%$ landmark, and the improvements in survival were
                      modest at best. For TC, early mortality requires attention,
                      whereas late mortality should be tackled for PC. For penile
                      cancer, the relatively high early mortality may suggest
                      delays in diagnosis and would require more public awareness
                      and encouragement of patients to seek medical opinion. In
                      FI, TC and penile cancer patients showed roughly double risk
                      of dying compared to the other Nordic countries, which
                      warrants further study and clinical attention.},
      keywords     = {conditional survival (Other) / periodic survival (Other) /
                      prognosis (Other) / time trends (Other) / treatment (Other)},
      cin          = {B062 / HD01 / C020},
      ddc          = {610},
      cid          = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331 /
                      I:(DE-He78)C020-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:37686536},
      pmc          = {pmc:PMC10486399},
      doi          = {10.3390/cancers15174261},
      url          = {https://inrepo02.dkfz.de/record/282727},
}